BioNexus Gene Lab Corp (BGLC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2025-08-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

17.82M
Year ended 2024-12-31
2023-12-31: 15.88M2024-12-31: 17.82M17.82M
2023-12-31 Weighted Average Diluted Shares (shares) 2024-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2024-12-3117.82M+12.2%2025-04-15, From 2024-01-01
2023-12-3115.88Mn/a2025-04-15, From 2023-01-01